Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. (Q27824811)
scientific article
Language:
Current Data About Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.
(P31) (Q13442814)
(P248)
(P698) 14993230
(P813) Sunday, November 13, 2016

(P50) (Q37830465)
(P1545) 1
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

(P304) 1201-1208
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

(P407) (Q1860)

(P433) 7
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

(P478) 22
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

(P577) Monday, March 1, 2004
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

(P921) (Q42824440)

(Q181600)

(Q188874)
(P887)

(Q420296)
(P887)

(Q25493920)
(P887)

(P1433) (Q400292)
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

(P1476) "Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor" (language: en)
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

(P2093) Neal J Meropol
(P1545) 2
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

Patrick J Loehrer
(P1545) 3
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

Michael N Needle
(P1545) 4
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

Justin Kopit
(P1545) 5
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

Robert J Mayer
(P1545) 6
(P248)
(P698) 14993230
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14993230%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, November 24, 2019

other details
description scientific article

External Links
(P356) 10.1200/JCO.2004.10.182
(P698) 14993230
(P3181) 2468325